Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
37952-36-6
1425973-15-4
1478016-33-9 | N-Boc-n-methyl-1,4-dioxaspiro[4.5]decan-8-amine | AA00HXIG | MFCD14582909
1509932-25-5 | N-(3-methoxypropyl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | AA00HXRD | MFCD27980604
1523617-81-3 | Methyl 6-cyanopyridazine-3-carboxylate | AA00HXXY | MFCD27986966
1544673-40-6 | 2-Chloro-5-hydroxymethylphenylboronic acid, pinacol ester | AA00HY5N | MFCD18729959
157134-90-2 | 5-[(oxiran-2-ylmethoxy)methyl]-2H-1,3-benzodioxole | AA00HYCT | MFCD06357334
16120-00-6 | 6-Methyl-1,2,4-triazin-5-ol | AA00HYKP | MFCD11108305
1632070-89-3 | Potassium trifluoro(naphthalen-2-ylmethyl)borate | AA00HYSB | MFCD28369609
1667753-41-4 | 4-Fluoro-2-(pyrrolidinomethyl)phenylboronic acid, pinacol ester | AA00HZ34 | MFCD20441917
1701449-18-4 | 3-Chloro-4,5-dimethoxyphenylboronic acid | AA00HZAP | MFCD20529446
173323-23-4 | (2-[2-(2,5-Dioxo-2,5-dihydro-1h-pyrrol-1-yl)ethoxy]ethoxy)acetic acid | AA00HZJ4 | MFCD22989469
